Grupo 6: Regulación y Homeostasis Inmune en Patologías Relacionadas con el Sistema Inmunológico
Código de grupo: 5.06
Tipo de grupo: Emergente
Descripción del grupo: Regulación y homeostasis inmune en patologías relacionadas con el sistema inmunológico
Jefe de Grupo: Rafael Correa Rocha y Marjorie Pion
| Integrantes del grupo | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investigadores y personal de apoyo | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Líneas de investigación | |
|---|---|
| Axis 1: New diagnostic and therapeutic techniques
L1: Development of extracellular vesicles produced in the culture of thymus regulatory T cells. Axis 2: Precision medicine L1: Development of genetically modified regulatory T cells for antigen specificity L2: Cell therapy with thyTreg cells in children with heart transplants L3: Immune regulation and immune disorders in paediatric diseases L4: Role of Treg cells in paediatric patients with Immunodeficiencies Axis 3: Infectious diseases L1: Study of the immune system of patients infected by SARS-CoV-2 or vaccinated by mRNA-based vaccines Axis 4: New diagnostic and therapeutic techniques L1: Allogeneic use of thyTreg in inflammatory diseases |
|
| First decile publications | 3 | 37,2 |
| First quartile publications | 10 | 90,6 |
| Second quartile publications | 1 | 5,9 |
| Third quartile publications | 0 | 0,0 |
| Total publications (including those without IF) | 11 | 96,5 |
